These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8690730

  • 1. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats.
    Matsuda Y, Matsumoto K, Ichida T, Nakamura T.
    J Biochem; 1995 Sep; 118(3):643-9. PubMed ID: 8690730
    [Abstract] [Full Text] [Related]

  • 2. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T.
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [Abstract] [Full Text] [Related]

  • 3. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats.
    Kusumoto K, Ido A, Moriuchi A, Katsura T, Kim I, Takahama Y, Numata M, Kodama M, Hasuike S, Nagata K, Uto H, Inui K, Tsubouchi H.
    Int J Mol Med; 2006 Mar; 17(3):503-9. PubMed ID: 16465399
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor gene therapy of liver cirrhosis in rats.
    Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J.
    Nat Med; 1999 Feb; 5(2):226-30. PubMed ID: 9930873
    [Abstract] [Full Text] [Related]

  • 5. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis.
    Kaido T, Seto S, Yamaoka S, Yoshikawa A, Imamura M.
    J Surg Res; 1998 Feb 01; 74(2):173-8. PubMed ID: 9587357
    [Abstract] [Full Text] [Related]

  • 6. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
    Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K.
    Hepatology; 1996 Sep 01; 24(3):636-42. PubMed ID: 8781336
    [Abstract] [Full Text] [Related]

  • 7. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH, Matsumoto K, Bessho K, Nakamura T.
    Am J Pathol; 2005 Apr 01; 166(4):1017-28. PubMed ID: 15793283
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
    Nakamura T, Sakata R, Ueno T, Sata M, Ueno H.
    Hepatology; 2000 Aug 01; 32(2):247-55. PubMed ID: 10915731
    [Abstract] [Full Text] [Related]

  • 9. Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries.
    Masunaga H, Fujise N, Shiota A, Ogawa H, Sato Y, Imai E, Yasuda H, Higashio K.
    Eur J Pharmacol; 1998 Jan 26; 342(2-3):267-79. PubMed ID: 9548396
    [Abstract] [Full Text] [Related]

  • 10. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy.
    Ozawa S, Uchiyama K, Nakamori M, Ueda K, Iwahashi M, Ueno H, Muragaki Y, Ooshima A, Yamaue H.
    Surgery; 2006 Apr 26; 139(4):563-73. PubMed ID: 16627068
    [Abstract] [Full Text] [Related]

  • 11. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, Nakai S, Morishita A, Uchida N, Masaki T, Watanabe S, Kuriyama S.
    Int J Mol Med; 2006 May 26; 17(5):857-64. PubMed ID: 16596271
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.
    Tomiya T, Ogata I, Fujiwara K.
    Am J Pathol; 1998 Sep 26; 153(3):955-61. PubMed ID: 9736044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis.
    Pines M, Knopov V, Genina O, Lavelin I, Nagler A.
    J Hepatol; 1997 Aug 26; 27(2):391-8. PubMed ID: 9288615
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impairment of activation of hepatocyte growth factor precursor into its mature form in rats with liver cirrhosis.
    Kaibori M, Inoue T, Sakakura Y, Oda M, Nagahama T, Kwon AH, Kamiyama Y, Miyazawa K, Okumura T.
    J Surg Res; 2002 Jul 26; 106(1):108-14. PubMed ID: 12127815
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous transfer of vascular endothelial growth factor and hepatocyte growth factor genes effectively promotes liver regeneration after hepatectomy in cirrhotic rats.
    Oe H, Kaido T, Furuyama H, Mori A, Imamura M.
    Hepatogastroenterology; 2004 Jul 26; 51(60):1641-7. PubMed ID: 15532795
    [Abstract] [Full Text] [Related]

  • 19. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes.
    Lin Y, Xie WF, Chen YX, Zhang X, Zeng X, Qiang H, Chen WZ, Yang XJ, Han ZG, Zhang ZB.
    Liver Int; 2005 Aug 26; 25(4):796-807. PubMed ID: 15998431
    [Abstract] [Full Text] [Related]

  • 20. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR.
    Hata J, Ikeda E, Uno H, Asano S.
    J Histochem Cytochem; 2002 Nov 26; 50(11):1461-8. PubMed ID: 12417611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.